Japan's medical standards are among the highest in the world. However, the number of approved pharmaceuticals available for treatment in Japan trails that of the West, and an awareness of this gap has been growing. Isn't it only natural that both Japanese patients and medical professionals would desire access to the most advanced pharmaceuticals already widely available in the West, thus increasing their number of treatment options?
 
While it is a fact that physicians in Japan may legally import medical products for treatment of patients in accordance with the Pharmaceutical Affairs Law, they face a complex and arduous application process; truly a significant barrier.
 
RHC was founded in 1998 with the purpose of providing physicians and medical institutions with a greater range of medical treatment options, with particular respect paid to the exportation of medical products to Japan for use in treatment of rare diseases.
 
We accurately and expediently navigate the complex application process to offer products of 100% certified quality at a fair price, freeing patients and medical professionals to give their undivided attention to the medical treatment at hand. This idea of assisting patients by providing a greater range of medical treatment options is our guiding principle.
 
In line with this, we will continue striving to accurately meet patient needs by providing required medical products on a global scale.

Yong Sa Lim
President